Novavax - a Leading Vaccine candidate for COVID19 Coronavirus

Novavax - a Leading Vaccine candidate for COVID19 Coronavirus

Created by:

FoundryBase App

Created this chunk

Visibility: Public (all visitors)

Resources in this Chunk:

Contains 2 resources

Novavax Gets $1.6 Billion for Coronavirus Vaccine From Operation Warp Speed - New York Times

Article 2020

Novavax Gets $1.6 Billion for Coronavirus Vaccine From Operation Warp Speed - New York Times
Saved by: FoundryBase
used in 1 chunk

Covid-19: Novavax vaccine shows 89% efficacy in UK trials - BBC News

Article 2021

Covid-19: Novavax vaccine shows 89% efficacy in UK trials - BBC News
Saved by: FoundryBase
used in 1 chunk

Created: Jan 29, 2021
Updated: Jan 23, 2025